Intellectual Ability in the Duchenne Muscular Dystrophy and Dystrophin Gene Mutation Location

1. Emery A, Muntoni F. Duchenne muscular dystrophy. 3rd ed. New York, NY: Oxford University Press, 2003.Search in Google Scholar

2. Cotton S, Voudouris NJ, Greenwood KM. Intelligence and Duchenne muscular dystrophy: Full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol. 2001; 43(7): 497-501.10.1017/S0012162201000913Search in Google Scholar

3. Cotton S, Voudouris N, Douglas J. Key findings from a meta-analytical study on intellectual functions in Duchenne muscular dystrophy. J Intell Disabil Res. 2000; 44(3-4): 248-248.Search in Google Scholar

4. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987; 50(3): 509-517.10.1016/0092-8674(87)90504-6Search in Google Scholar

5. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988; 2(1): 90-95.10.1016/0888-7543(88)90113-9Search in Google Scholar

6. Lidov HG, Byers TJ, Watkins SC, Kunkel LM. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature. 1990; 348(6303): 725-728.10.1038/348725a02259381Search in Google Scholar

7. Tokarz SA, Duncan NM, Rash SM, Sadeghi A, Dewan AK, Pillers DA. Redefinition of dystrophin isoform distribution in mouse tissue by RTPCR implies role in nonmuscle manifestations of duchenne muscular dystrophy. Mol Genet Metab. 1998; 65(4): 272-281.10.1006/mgme.1998.27639889014Search in Google Scholar

8. Anderson JL, Head SI, Rae C, Morley JW. Brain function in Duchenne muscular dystrophy. Brain. 2002; 125(1): 4-13.10.1093/brain/awf01211834588Search in Google Scholar

9. Perronnet C, Vaillend C. Dystrophins, utrophins, and associated scaffolding complexes: Role in mammalian brain and implications for therapeutic strategies. J Biomed Biotechnol. 2010; 2010: 849426. doi: 10.1155/2010/ 849426.Search in Google Scholar

10. Pillers DA, Bulman DE, Weleber RG, Sigesmund DA, Musarella MA, Powell BR, et al. Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nat Genet. 1993; 4(1): 82-86.10.1038/ng0593-828513332Search in Google Scholar

11. Lidov HG, Selig S, Kunkel LM. Dp140: A novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet. 1995; 4(3): 329-335.10.1093/hmg/4.3.3297795584Search in Google Scholar

12. Byers TJ, Lidov HG, Kunkel LM. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet. 1993; 4(1): 77-81.10.1038/ng0593-778513330Search in Google Scholar

13. Bar S, Barnea E, Levy Z, Neuman S, Yaffe D, Nudel U. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem J. 1990; 272(2): 557-560.10.1042/bj272055711497402176467Search in Google Scholar

14. Taylor PJ, Betts GA, Maroulis S, Gilissen C, Pedersen RL, Mowat DR, et al. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS One. 2010; 5(1): e8803. doi: 10.1371/ journal.pone.0008803.10.1371/journal.pone.0008803Search in Google Scholar

15. Daoud F, Angeard N, Demerre B, Martie I, Benyaou R, Leturcq F, et al. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression. Hum Mol Genet. 2009; 18(20): 3779-3794.10.1093/hmg/ddp320Search in Google Scholar

16. Tozawa T, Itoh K, Yaoi T, Tando S, Umekage M, Dai H, et al. The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brain. Mol Neu-robiol. 2012; 45(2): 287-297.10.1007/s12035-012-8233-5Search in Google Scholar

17. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligationdependent probe amplification. Nucleic Acids Res. 2002; 30(12): e57. doi: 10.1093/nar/gnf056.10.1093/nar/gnf056Search in Google Scholar

18. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988; 16(23): 11141-11156.10.1093/nar/16.23.11141Search in Google Scholar

19. Beggs AH, Koenig M, Boyce FM, Kunkel LM.Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990; 86(1): 45-48.10.1007/BF00205170Search in Google Scholar

20. Kunkel LM, Snyder JR, Beggs AH, Boyce FM, Feener CA. Searching for dystrophin gene deletions in patients with atypical presentations. In: Lindsten J, Petterson U, Eds. Etiology of Human Diseases at the DNA Level. New York, NY: Raven Press. 1991: 51-61.Search in Google Scholar

21. Den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat. 2000; 15(1): 7-12.10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-NSearch in Google Scholar

22. Bushby KM, Appleton R, Anderson LV, Welch JL, Kelly P, Gardner-Medwin D. Deletion status and intellectual impairment in Duchenne muscular dystrophy. Dev Med Child Neurol. 1995; 37(3): 260-269.10.1111/j.1469-8749.1995.tb12000.xSearch in Google Scholar

23. Desguerre I, Christov C, Mayer M, Zeller R, Becane HM, Bastuji-Garin S, et al. Clinical heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS One. 2009; 4(2): e4347. doi: 10.1371/ ournal.pone.0004347. 10.1371/journal.pone.0004347Search in Google Scholar

24. Wechsler D. Manual for the Wechsler Intelligence Scale for Children, 3rd ed. New York, NY: Psychological Corporation, 1991.Search in Google Scholar

25. Brunet O, Lezine PUF. Le Developpement Psychologique del al Premiere Enfance. Issy-les- Moulineaux. France: Editions Scientifiques et Psychotechniques, 1951.Search in Google Scholar

26. Doll EA. Vineland Social Maturity Scale. Oxford, UK: Educational Test Bureau, 1947.Search in Google Scholar

27. Hinton VJ, Fee RJ, Goldstein EM, De Vivo DC. Verbal and memory skills in males with Duchenne muscular dystrophy. Dev Med Child Neurol. 2007; 49(2): 123-128.10.1111/j.1469-8749.2007.00123.xSearch in Google Scholar

28. D’Angelo MG, Lorusso ML, Civati F, Comi GP, Magri F, Del Bo R, et al. Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site. Pediatr Neurol. 2011; 45(5): 292-299.10.1016/j.pediatrneurol.2011.08.003Search in Google Scholar

29. Wingeier K, Giger E, Strozzi S, Kreis R, Joncourt F, Conrad B, et al. Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy. J Clin Neurosci. 2011; 18(1): 90-95.10.1016/j.jocn.2010.07.118Search in Google Scholar

30. Lorusso ML, Civati F, Molteni M, Turconi AC, Bresolin N, D’Angelo MG. Specific profiles of neurocognitive and reading functions in a sample of 42 Italian boys with Duchenne Muscular Dystrophy. Child Neuropsychol. 2013; 19(4): 350-369.10.1080/09297049.2012.660912Search in Google Scholar

31. Chamova T, Guergueltcheva V, Raycheva M, Todorov T, Genova F, Bichev S, et al. Association between loss of Dp140 and cognitive impairment in Du-henne and Becker dystrophies. Balkan J Med Genet. 2013; 16(1): 21-30.10.2478/bjmg-2013-0014Search in Google Scholar

32. Knuesel I, Bornhauser BC, Zuellig RA, Heller F, Schaub MC, Fritschy JM. Differential expression of utrophin and dystrophin in CNS neurons: An in situ hybridization and immunohistochemical study. J Comp Neurol. 2000; 422(4): 594-611.10.1002/1096-9861(20000710)422:4<594::AID-CNE8>3.0.CO;2-QSearch in Google Scholar

33. Sekiguchi M, Zushida K, Yoshida M, Maekawa M, Kamichi S, Yoshida M, et al. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain. 2009; 132(1): 124-135.10.1093/brain/awn253Search in Google Scholar

34. Moizard MP, Toutain A, Fournier D, Berret F, Raynaud M, Billard C, et al. Severe cognitive impairment in DMD: Obvious clinical indication for Dp71 isoform point mutation screening. Eur J Hum Genet. 2000; 8(7): 552-556.10.1038/sj.ejhg.5200488Search in Google Scholar

35. Moizard MP, Billard C, Toutain A, Berret F, Marmin N, Moraine C. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? Am J Med Genet. 1998; 80(1): 32-41.10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-YSearch in Google Scholar

36. Chelly J, Khelfaoui M, Francis F, Cherif B, Bienvenu T. Genetics and pathophysiology of mental retardation. Eur J Hum Genet. 2006; 14(6): 701-713.10.1038/sj.ejhg.5201595Search in Google Scholar

37. Felisari G, Martinelli Boneschi F, Bardoni A, Sironi M, Comi GP, Robotti M, et al. Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology. 2000; 55(4): 559-564.10.1212/WNL.55.4.559Search in Google Scholar

38. Haenggi T, Soontornmalai A, Schaub MC, Fritschy JM. The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain. Neuroscience. 2004; 129(2): 403-413.10.1016/j.neuroscience.2004.06.07915501597Search in Google Scholar

39. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP. Identification and characterization of the dystrophin anchoring site on β-dystroglycan. J Biol Chem. 1995; 270(45): 27305-27310.10.1074/jbc.270.45.273057592992Search in Google Scholar

40. Sigelman C, Rider EA. Life-Span Human Development, 7th ed. Belmont, CA: Wadsworth Cengage Learning, 2012.Search in Google Scholar

41. Wu JY, Kuban KC, Allred E, Shapiro F, Darras BT. Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol. 2005; 20(10): 790-795.10.1177/0883073805020010020116417872Search in Google Scholar

42. Ferlini A, Neri M, Gualandi F. The medical genetics of dystrophinopathies: Molecular genetic diagnosis and its impact on clinical practice. Neuromusc Disord. 2013; 23(1): 4-14. 10.1016/j.nmd.2012.09.00223116935Search in Google Scholar